Immunogenicity and Safety of Fluarix/ Influsplit SSW 2010/2011 or Pandemrix.
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2016
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza A virus H1N1 subtype; Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 17 Mar 2012 Actual end date (24 Feb 2011) added as reported by European Clinical Trials Database.
- 31 Mar 2011 Status changed from not yet recruiting to discontinued.
- 23 Jul 2010 New trial record